Celecoxib Oral Solution Approved for Acute Migraine Treatment
Celecoxib Oral Solution Approved for Acute Migraine Treatment
celecoxib
Dr. Reddy’s Laboratories Receives FDA Approval for ELYXYB™ (celecoxib oral solution) in the U.S. for Acute Treatment of Migraine with or without Aura
https://www.businesswire.com/news/home/20200506005819/en/Dr.-Reddys-Laboratories-Received-Approval-NDA-ELYXYB%E2%84%A2
Dr. Reddy’s Laboratories Received Approval for Their NDA, ELYXYB™ (celecoxib oral solution) 25 mg/mL, in the U.S.
